Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016

October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3...

prostate cancer, SBRT, stereotactic body radiotherapy, ASTRO 2016 study, Robert Meier, control, side effects, toxicity
News | Radiation Therapy | October 06, 2016

October 6, 2016 — High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-...

prostate cancer, ProtecT trial findings, ASTRO 2016, radiation therapy
News | Radiation Therapy | October 03, 2016

September 29, 2016 — The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors...

prostate cancer, hormone therapy, cardiac risk factors, Yale Cancer Center study, ASTRO 2016
News | Cardio-oncology | September 28, 2016

September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy...

prostate cancer, hypofractionated radiationt therapy, accelerated RT, side effects, treatment time, ASTRO 2016, NRG Oncology/RTOG 0415
News | Prostate Cancer | September 27, 2016

September 27, 2016 — For men with early stage, low-risk...

prostate cancer, novel intrinsic subtypes, study, ASTRO 2016
News | Prostate Cancer | September 26, 2016

September 26, 2016 — In the largest study of its kind to date, researchers have identified and validated three...

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy
News | Radiation Therapy | September 07, 2016

September 7, 2016 — The American Society for...

Axumin, fluciclovine F-18 injection, first injection, Northside Hospital Atlanta
News | Radiopharmaceuticals and Tracers | September 07, 2016

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...

PRI-MUS protocol, ExactVu micro-ultrasound, prostate cancer, lesion identification, The Journal of Urology study

ExactVu micro-ultrasound system image courtesy of Exact Imaging.

News | Prostate Cancer | August 08, 2016

July 28, 2016 — Exact Imaging announced that The Journal of Urology has published the initial results supporting the...

metastatic prostate cancer incidence, Northwestern Medicine study, Edward Schaeffer, Adam Weiner
Feature | Prostate Cancer | July 25, 2016

July 25, 2016 — The number of new cases of metastatic...

photoacoustic imaging

Images of prostate cells captured through photoacoustic imaging. Top: cancer cells that express the targeted cancer marker, PSMA; bottom: cells that lack PSMA. A research team led by Kent Nastiuk of Roswell Park Cancer Institute has published new evidence that this approach can be a useful tool in monitoring and selecting treatments for many cancers.

News | Prostate Cancer | July 15, 2016

While active surveillance is often recommended for patients with nonaggressive...

PET, mpMRI, prostate cancer detection, targeted biopsies, University of Michigan study, Morand Piert

The figure shows a Gleason 3+4 prostate cancer (arrows) as identified on T2-weighted (A) and diffusion-weighted (B) MRI, F-18-choline PET (C), as well as PET/MRI (D).

News | Prostate Cancer | July 14, 2016

July 14, 2016 — Adding F-18-choline positron...

prostate cancer, MRI-guided biopsies, Overlake Medical Center Washington
News | Prostate Cancer | July 13, 2016

July 13, 2016 — Overlake Medical Center, Bellevue, Wash., recently announced it is formally adopting a new standard...

News | Prostate Cancer | June 17, 2016

June 17, 2016 — Decatur Memorial Hospital, Decatur, Ill., is now offering C-11 choline...

UAB, iSR'obot Mona Lisa, prostate cancer, image-guided biopsy

Jeffrey Nix, M.D., left, and Soroush Rais-Bahrami, M.D., with the iSR’obotTM Mona Lisa , a new image guided device for diagnosing prostate cancer. Image courtesy of UAB News.

News | Biopsy Systems | June 09, 2016

June 9, 2016 — The University of Alabama at Birmingham (UAB) announced it is one of two beta sites in the United...

NaF-PET/CT, sodium fluoride, advanced prostate cancer, metastases, pilot study
News | PET-CT | June 07, 2016

June 7, 2016 — A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium...